Re:Diabetes complications soar in US, but not Canada, as tee...
by GeekyBear on Thursday May 09, 2019 @02:56PM
(#19871085)
Obama certainly campaigned on putting a stop to drug company price gouging inside the US by finally allowing Americans to purchase prescription drugs from Canada where price gouging is not allowed.
However, a back room deal was quickly cut.
>WASHINGTON — After weeks of talks, drug industry lobbyists were growing nervous. To cut a deal with the White House on overhauling health care, they needed to be sure that President Obama would stop a proposal intended to bring down medicine prices.
On June 3, 2009, one of the lobbyists e-mailed Nancy-Ann DeParle, the president’s health care adviser. Ms. DeParle reassured the lobbyist. Although Mr. Obama was overseas, she wrote, she and other top officials had “made decision, based on how constructive you guys have been, to oppose importation” on a different proposal.
Just like that, Mr. Obama’s staff signaled a willingness to put aside support for the reimportation of prescription medicines at lower prices and by doing so solidified a compact with an industry the president had vilified on the campaign trail.
Supposedly, the industry promised to control costs themselves in exchange for the deal, but looking at the data on drug prices, we know they never followed through.
However, a back room deal was quickly cut.
>WASHINGTON — After weeks of talks, drug industry lobbyists were growing nervous. To cut a deal with the White House on overhauling health care, they needed to be sure that President Obama would stop a proposal intended to bring down medicine prices.
On June 3, 2009, one of the lobbyists e-mailed Nancy-Ann DeParle, the president’s health care adviser. Ms. DeParle reassured the lobbyist. Although Mr. Obama was overseas, she wrote, she and other top officials had “made decision, based on how constructive you guys have been, to oppose importation” on a different proposal.
Just like that, Mr. Obama’s staff signaled a willingness to put aside support for the reimportation of prescription medicines at lower prices and by doing so solidified a compact with an industry the president had vilified on the campaign trail.
https://www.nytimes.com/2012/06/09/us/politics/e-mails-revea...
Supposedly, the industry promised to control costs themselves in exchange for the deal, but looking at the data on drug prices, we know they never followed through.